Thanks doc, that was my point. If this is slowing down the trial, or slowing down our listing of NGIO which will bring in millions and millions of needed dollars, why bother? A peer review could be done later after NGIO was listed and a positive review could then add support to the stock price. By doing it now, to maybe get a higher initial price (MAYBE!), then you lose that ammo for after NGIO is listed and needs the support.

Quote:

---

Not sure what Rich was referring to and exactly why they are taking this step. Obviously there is benefit to having positive review. Prestige and credibility goes way up. As long as the trial process continues.

Read More: https://investorshangout.com/post/newpost/622...z6gKw9goSY

---